BACKGROUND: Abnormal adhesiveness of red blood cells to endothelium has been implicated in vaso-occlusive crisis of sickle cell disease. The present study examined whether the SAD mouse model exhibits the same abnormalities of red blood cell adhesion as those found in human sickle cell disease. DESIGN AND METHODS: The repertoire of adhesive molecules on murine erythrocytes and bEnd.3 microvascular endothelial cells was determined by flow cytometry using monoclonal antibodies or by western blotting. Adhesion was investigated in dynamic conditions and measured at different shear stresses. RESULTS: CD36, CD47 and intercellular adhesion molecular-4, but not Lutheran blood group antigen/basal cell adhesion molecule, are present on mouse mature erythrocytes. alpha(4)beta(1) are not expressed on SAD and wild type reticulocytes. Endothelial bEnd.3 cells express alpha(V)beta(3), alpha(4)beta(1), CD47, vascular cell adhesion molecule-1, and Lutheran blood group antigen/basal cell adhesion molecule, but not CD36. Adhesion of SAD red cells is: (i) 2- to 3-fold higher than that of wild type red cells; (ii) further increased on platelet activating factor-activated endothelium; (iii) not stimulated by epinephrine; (iv) inhibited after treating the endothelium with a peptide reproducing one of the binding sequences of mouse intercellular adhesion molecular-4, or with mon-oclonal antibody against murine alpha(v) integrin; and (v) inhibited after pretreatment of red blood cells with anti-mouse CD36 monoclonal antibodies. The combination of treatments with intercellular adhesion molecular-4 peptide and anti-CD36 monoclonal antibodies eliminates excess adhesion of SAD red cells. The phosphorylation state of intercellular adhesion molecular-4 and CD36 is probably not involved in the over-adhesiveness of SAD erythrocytes. CONCLUSIONS: Intercellular adhesion molecular-4/alpha(v)beta(3) and CD36/thrombospondin interactions might contribute to the abnormally high adhesiveness of SAD red cells. The SAD mouse is a valuable animal model for investigating adhesion processes of sickle cell disease.
BACKGROUND: Abnormal adhesiveness of red blood cells to endothelium has been implicated in vaso-occlusive crisis of sickle cell disease. The present study examined whether the SADmouse model exhibits the same abnormalities of red blood cell adhesion as those found in human sickle cell disease. DESIGN AND METHODS: The repertoire of adhesive molecules on murine erythrocytes and bEnd.3 microvascular endothelial cells was determined by flow cytometry using monoclonal antibodies or by western blotting. Adhesion was investigated in dynamic conditions and measured at different shear stresses. RESULTS:CD36, CD47 and intercellular adhesion molecular-4, but not Lutheran blood group antigen/basal cell adhesion molecule, are present on mouse mature erythrocytes. alpha(4)beta(1) are not expressed on SAD and wild type reticulocytes. Endothelial bEnd.3 cells express alpha(V)beta(3), alpha(4)beta(1), CD47, vascular cell adhesion molecule-1, and Lutheran blood group antigen/basal cell adhesion molecule, but not CD36. Adhesion of SAD red cells is: (i) 2- to 3-fold higher than that of wild type red cells; (ii) further increased on platelet activating factor-activated endothelium; (iii) not stimulated by epinephrine; (iv) inhibited after treating the endothelium with a peptide reproducing one of the binding sequences of mouse intercellular adhesion molecular-4, or with mon-oclonal antibody against murinealpha(v) integrin; and (v) inhibited after pretreatment of red blood cells with anti-mouseCD36 monoclonal antibodies. The combination of treatments with intercellular adhesion molecular-4 peptide and anti-CD36 monoclonal antibodies eliminates excess adhesion of SAD red cells. The phosphorylation state of intercellular adhesion molecular-4 and CD36 is probably not involved in the over-adhesiveness of SAD erythrocytes. CONCLUSIONS: Intercellular adhesion molecular-4/alpha(v)beta(3) and CD36/thrombospondin interactions might contribute to the abnormally high adhesiveness of SAD red cells. The SADmouse is a valuable animal model for investigating adhesion processes of sickle cell disease.
Authors: I Coste; J F Gauchat; A Wilson; S Izui; P Jeannin; Y Delneste; H R MacDonald; J Y Bonnefoy; T Renno Journal: Blood Date: 2001-06-15 Impact factor: 22.113
Authors: G A Lutty; M Taomoto; J Cao; D S McLeod; P Vanderslice; B W McIntyre; M E Fabry; R L Nagel Journal: Invest Ophthalmol Vis Sci Date: 2001-05 Impact factor: 4.799
Authors: Gloria Lee; Frances A Spring; Stephen F Parsons; Tosti J Mankelow; Luanne L Peters; Mark J Koury; Narla Mohandas; David J Anstee; Joel Anne Chasis Journal: Blood Date: 2002-10-24 Impact factor: 22.113
Authors: K Lee; P Gane; F Roudot-Thoraval; B Godeau; D Bachir; F Bernaudin; J P Cartron; F Galactéros; P Bierling Journal: Blood Date: 2001-08-15 Impact factor: 22.113
Authors: Patrick C Hines; Qin Zen; Sharran N Burney; Deborah A Shea; Kenneth I Ataga; Eugene P Orringer; Marilyn J Telen; Leslie V Parise Journal: Blood Date: 2002-12-27 Impact factor: 22.113
Authors: Marilyn J Telen; Ted Wun; Timothy L McCavit; Laura M De Castro; Lakshmanan Krishnamurti; Sophie Lanzkron; Lewis L Hsu; Wally R Smith; Seungshin Rhee; John L Magnani; Helen Thackray Journal: Blood Date: 2015-03-02 Impact factor: 22.113
Authors: Virginia Pretini; Mischa H Koenen; Lars Kaestner; Marcel H A M Fens; Raymond M Schiffelers; Marije Bartels; Richard Van Wijk Journal: Front Physiol Date: 2019-07-31 Impact factor: 4.566
Authors: Megha Kaushal; Colleen Byrnes; Zarir Khademian; Natalie Duncan; Naomi L C Luban; Jeffery L Miller; Ross M Fasano; Emily Riehm Meier Journal: PLoS One Date: 2016-04-26 Impact factor: 3.240